Cefoap T 500mg/62.5mg Injection
Marketer
Apkavit Lifesciences
Salt Composition
Cefoperazone (500mg) + Tazobactum (62.5mg)
Overview Cefoap T 500mg/62.5mg Injection
Cefoap T 500mg/62.5mg injection, a dual-action medication, combats diverse bacterial infections. Its mechanism halts microbial proliferation, preventing infection spread. Administration requires a healthcare provider's oversight; strict adherence to the prescribed schedule is crucial. Complete the full treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, edema, respiratory distress). Disclose all current medications to your physician before use. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occur. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor might order lab tests to monitor treatment response.
Uses of Cefoap T 500mg/62.5mg Injection
Managing bacterial infections
Major Benefits of Cefoap T 500mg/62.5mg Injection:
This medication will be administered by your physician or their designated nurse; please refrain from self-medicating.
Common Side effects of Cefoap T 500mg/62.5mg Injection:
- Diarrhea
- Abnormal liver function tests
- Allergic reaction
- Anemia (low number of red blood cells)
How to use Cefoap T 500mg/62.5mg Injection:
Administering this medication will be done by your physician or their qualified assistant; self-medication is strictly prohibited.
How Cefoap T 500mg/62.5mg Injection works:
Cefoap T 500mg/62.5mg Injection unites Cefoperazone, a bacteria-fighting antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum complements this by countering bacterial resistance mechanisms, thus bolstering Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Cefoap T 500mg/62.5mg Injection and alcohol can trigger adverse reactions, including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a Disulfiram-like effect).
PregnancySAFE IF PRESCRIBED
The injectable medication Cefoap T (500mg/62.5mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Cefoap T 500mg/62.5mg injections are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to infants.
DrivingCONSULT YOUR DOCTOR
Cefoap T 500mg/62.5mg Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefoap T 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefoap T 500mg/62.5mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Cefoap T 500mg/62.5mg Injection :
Omitting a scheduled dose of Cefoap T 500mg/62.5mg Injection warrants immediate physician consultation.
Facts to Know About Cefoap T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
3,018 People bought this recently